Barclays Maintains Overweight on CBRE Group, Raises Price Target to $178

Benzinga Newsdesk www.benzinga.com Positive 63.5%

Neg 0% Neu 0% Pos 63.5%

Barclays analyst Brendan Lynch maintains CBRE Group (NYSE:CBRE) with a Overweight and raises the price target from $175 to $178.